Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
British Journal of Clinical Pharmacology2012Vol. 76(1), pp. 99–106
Citations Over TimeTop 25% of 2012 papers
April Barbour, Lea Sarov‐Blat, Gengqian Cai, Michael J. Fossler, Dennis L. Sprecher, Johann Graggaber, Adam McGeoch, Jo Maison, Joseph Cheriyan
Abstract
A single IV infusion of losmapimod in healthy volunteers was safe and well tolerated, and may potentially serve as an initial loading dose in acute coronary syndrome as rapid exposure is achieved.
Related Papers
- Phase I clinical trial of cefditoren pivoxil (ME 1207): pharmacokinetics in healthy volunteers.(1997)
- → Pharmacokinetic analysis of new synthetic antimalarial N-251(2019)4 cited
- → Studies on the Metabolic Fate of 3H-TJN-101. (I): Absorption, Distribution and Excretion following Single Oral Administration to Rats.(1992)2 cited
- [Effect of constituents combination on pharmacokinetics of Shuxiong tablet].(2009)
- Pharmacokinetics of 2 epimers of glycyrrhizic acid in rats(2010)